Why would improved industry access to a patient population for a study benefit Georgia residents?
It is important to note that while patients may see a therapeutic relief of symptoms from their disease in a clinical trial, few do. The drug may not work well for them, may be at a dose being explored but too low or too high for them, or the side effects from the product outweigh the interest of their health to remain in the study. Perhaps the least explored benefit of a clinical trial, however, is the benefit to patients from simple participation and the medical assessments typically done. Sponsors want to ensure that any underlying illness a patient has prior to exposure to the investigational product does not transfer as a cause by the product in testing. In more simple terms, if you have a common cold and start a clinical trial with a stuffy nose and fever, the new product has nothing to do with your cold and shouldnt be blamed (unless it makes the cold worse). Considerable resources are spent to assess patients health through thorough medical screening and physical exams. Dependi
